Mechanisms of acute pulmonary dysfunction induced by fibrinogen degradation product D.
D000208:Acute Disease; D000472:Alkalosis, Respiratory / Q000209:etiology; D000818:Animals; D002245:Carbon Dioxide / Q000097:blood; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000009:adverse effects*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008171:Lung Diseases / Q000097:blood / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption; D010313:Partial Pressure; D011817:Rabbits; D012120:Respiration Disorders / Q000209:etiology; D012711:Serum Albumin, Radio-Iodinated; D013921:Thrombocytopenia / Q000209:etiology
D005338:Fibrin Fibrinogen Degradation Products; D006634:Histamine H1 Antagonists; D012711:Serum Albumin, Radio-Iodinated; D002245:Carbon Dioxide; D010100:Oxygen